Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases successfully treated with CIP,% cases successfully treated with TET,% cases successfully treated with CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"6,603 (5,060, 8,172)","51.7% (35.6%, 75.5%)","0.0% (0.0%, 0.0%)","0.0% (0.0%, 0.0%)","51.7% (35.6%, 75.5%)","12.9 (8.9, 18.9)","0.0 (0.0, 0.0)","0.0 (0.0, 0.0)","12.9 (8.9, 18.9)",,,,,
"(p=0.750, q=0.975, c=0.500)","6,819 (5,267, 8,456)","61.7% (43.5%, 91.6%)","14.0% (9.0%, 21.5%)","2.1% (1.3%, 3.8%)","45.5% (30.8%, 66.4%)","15.4 (10.9, 22.9)","3.5 (2.3, 5.4)","0.5 (0.3, 1.0)","11.4 (7.7, 16.6)","3.3% (0.8%, 6.0%)","19.6% (0.4%, 35.9%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-11.6% (-26.4%, -0.2%)"
"(p=0.750, q=0.975, c=0.750)","6,968 (5,394, 8,508)","63.2% (43.6%, 91.8%)","21.4% (13.5%, 31.8%)","3.2% (1.9%, 5.6%)","38.6% (26.5%, 54.3%)","15.8 (10.9, 22.9)","5.3 (3.4, 7.9)","0.8 (0.5, 1.4)","9.6 (6.6, 13.6)","5.5% (2.6%, 9.7%)","22.9% (0.7%, 42.1%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-24.8% (-40.4%, -11.2%)"
"(p=0.750, q=0.975, c=1.000)","7,116 (5,498, 8,800)","64.0% (43.7%, 91.6%)","28.6% (18.2%, 46.4%)","4.3% (2.5%, 7.6%)","31.1% (20.7%, 43.9%)","16.0 (10.9, 22.9)","7.2 (4.6, 11.6)","1.1 (0.6, 1.9)","7.8 (5.2, 11.0)","7.8% (3.7%, 13.8%)","24.5% (0.7%, 46.3%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-39.4% (-55.2%, -24.0%)"
